According to him, there could be limited windows where IPOs would be possible, bringing a lot of focus "back to the basics" ...
Completed enrollment of Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps; top-line data expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback